Noval Machine Learning Approach for Classifying Clinically Actionable Genetic Mutations in Cancer Patients

[1]  Zhongming Zhao,et al.  Classification of Cancer Primary Sites Using Machine Learning and Somatic Mutations , 2015, BioMed research international.

[2]  Brendan J. Frey,et al.  Machine Learning in Genomic Medicine: A Review of Computational Problems and Data Sets , 2016, Proceedings of the IEEE.

[3]  Dimitrios I. Fotiadis,et al.  Machine learning applications in cancer prognosis and prediction , 2014, Computational and structural biotechnology journal.

[4]  Jinsung Yoon,et al.  Discovery and Clinical Decision Support for Personalized Healthcare , 2017, IEEE Journal of Biomedical and Health Informatics.

[5]  Elvira Mayordomo,et al.  Machine learning classifier for identification of damaging missense mutations exclusive to human mitochondrial DNA-encoded polypeptides , 2017, BMC Bioinformatics.

[6]  Zhiping Zhang,et al.  Genomic profiling by machine learning , 2011, 2011 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW).

[7]  Anuradha D. Thakare,et al.  Intelligent Classification of Clinically Actionable Genetic Mutations Based on Clinical Evidences , 2018, 2018 Fourth International Conference on Computing Communication Control and Automation (ICCUBEA).

[8]  William Stafford Noble,et al.  Machine learning applications in genetics and genomics , 2015, Nature Reviews Genetics.